BR vs NBIX

Comparison between Broadridge Financial Solutions Inc (BR, Company) and Neurocrine Biosciences Inc (NBIX, Company).

BR is from the Technology sector, while NBIX is from the Healthcare sector.

5-Year PerformanceNBIX has outperformed BR, delivering a return of +9.6% compared to -1.6%

BR vs NBIX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BR(COMPANY)	NBIX(COMPANY)
Market Cap	$16B	$16B
Max Drawdown	59.43%	97.21%
Sharpe Ratio	-2.10	0.80
5Y Beta	0.49	0.80
Industry	Information Technology Services	Drug Manufacturers - Specialty & Generic
P/E Ratio	14.58	23.66
Forward P/E	13.14	22.32
PEG Ratio	0.36	0.20
Dividend Yield	2.73%	N/A
5Y Dividends CAGR	22.61%	N/A
5Y EPS CAGR	16.10%	9.25%
Debt to Equity	114.48%	0.00%
Free Cash Flow Yield	8.27%	5.19%
P/S Ratio	2.17	5.13
P/B Ratio	5.65	4.67

Market Cap

$16B

Winner

NBIX

$16B

Max Drawdown

Winner

59.43%

NBIX

97.21%

Sharpe Ratio

-2.10

Winner

NBIX

0.80

5Y Beta

Winner

0.49

NBIX

0.80

Industry

Information Technology Services

NBIX

Drug Manufacturers - Specialty & Generic

P/E Ratio

Winner

14.58

NBIX

23.66

Forward P/E

Winner

13.14

NBIX

22.32

PEG Ratio

0.36

Winner

NBIX

0.20

Dividend Yield

2.73%

NBIX

N/A

5Y Dividends CAGR

22.61%

NBIX

N/A

5Y EPS CAGR

Winner

16.10%

NBIX

9.25%

Debt to Equity

114.48%

Winner

NBIX

0.00%

Free Cash Flow Yield

Winner

8.27%

NBIX

5.19%

P/S Ratio

Winner

2.17

NBIX

5.13

P/B Ratio

5.65

Winner

NBIX

4.67

BR vs NBIX - Historical Returns

Returns include dividend reinvestment.

Period	BR	NBIX
1 month	-8.87%	+3.14%
3 months	-19.73%	+27.21%
6 months	-39.58%	+9.55%
1 year	-42.17%	+28.47%
5 years(CAGR)	-1.58%	+9.59%
10 years(CAGR)	+9.70%	+14.23%
Max(CAGR)	+12.88%	+12.51%

-8.87%

Winner

NBIX

+3.14%

-19.73%

Winner

NBIX

+27.21%

-39.58%

Winner

NBIX

+9.55%

-42.17%

Winner

NBIX

+28.47%

5Y(CAGR)

-1.58%

Winner

NBIX

+9.59%

10Y(CAGR)

+9.70%

Winner

NBIX

+14.23%

Max(CAGR)

Winner

+12.88%

NBIX

+12.51%

BR vs NBIX - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	BR	NBIX
2026	-37.46%	+14.95%
2025	-0.07%	+2.88%
2024	+14.93%	+3.62%
2023	+55.72%	+9.73%
2022	-24.48%	+35.01%
2021	+22.48%	-11.16%
2020	+26.05%	-11.50%
2019	+32.19%	+53.36%
2018	+7.61%	-9.95%
2017	+39.87%	+100.70%
2016	+29.09%	-26.07%
2015	+20.42%	+147.68%
2014	+20.28%	+133.93%
2013	+72.04%	+14.74%
2012	+3.94%	-12.51%
2011	+4.17%	+10.82%
2010	-0.71%	+184.01%
2009	+62.06%	-16.82%
2008	-42.76%	-29.20%
2007	+16.00%	-55.79%
2006	N/A	-83.61%
2005	N/A	+27.97%
2004	N/A	-11.17%
2003	N/A	+20.11%
2002	N/A	-9.71%
2001	N/A	+59.40%
2000	N/A	+31.89%
1999	N/A	+253.57%

BR vs NBIX Drawdown Comparison

The maximum drawdown for BR was -59.02%, occurring on Nov 20, 2008. Recovery took 592 trading sessions.

The maximum drawdown for NBIX was -97.21%, occurring on Nov 12, 2009. Recovery took 2931 trading sessions.

The current BR drawdown is -47.92%. The current NBIX drawdown is -3.42%.

Rank	BR	NBIX
#1	-59.02% Dec 13, 2007 - Apr 22, 2010	-97.21% Mar 15, 2006 - Nov 2, 2017
#2	-47.92% Aug 6, 2025 - Jun 22, 2026	-66.15% Mar 3, 2000 - Nov 20, 2001
#3	-36.87% Sep 14, 2018 - Jul 27, 2020	-54.12% Dec 24, 2001 - Jun 5, 2003
#4	-27.01% Dec 27, 2021 - Aug 12, 2022	-50.71% Apr 27, 2004 - Feb 27, 2006
#5	-26.85% Aug 12, 2022 - Aug 11, 2023	-46.39% Jul 15, 2020 - Jan 17, 2024
#6	-23.75% May 11, 2007 - Nov 8, 2007	-45.71% Sep 4, 2018 - Jun 19, 2020
#7	-22.38% May 3, 2010 - Apr 27, 2011	-42.89% Jan 30, 2025 - Nov 5, 2025
#8	-21.89% Jul 7, 2011 - Feb 1, 2012	-28.57% Jan 21, 2000 - Feb 16, 2000
#9	-18.05% Feb 27, 2012 - Mar 14, 2013	-27.12% Aug 1, 2024 - Jan 30, 2025
#10	-16.66% Oct 28, 2015 - Mar 31, 2016	-22.86% Dec 2, 1999 - Dec 13, 1999
#11	-14.79% Sep 7, 2016 - May 10, 2017	-21.32% Jun 16, 2003 - Jan 23, 2004
#12	-11.79% Apr 2, 2025 - Jul 24, 2025	-20.90% Dec 10, 2025 - May 12, 2026
#13	-11.67% Dec 24, 2013 - May 13, 2014	-19.01% Dec 29, 1999 - Jan 10, 2000
#14	-11.41% Aug 10, 2015 - Oct 2, 2015	-18.53% Mar 9, 2018 - May 15, 2018
#15	-11.06% Sep 11, 2023 - Nov 28, 2023	-13.74% Jan 26, 2004 - Mar 4, 2004